• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The year in cardiovascular medicine 2020: valvular heart disease.

作者信息

Bermejo Javier, Postigo Andrea, Baumgartner Helmut

机构信息

Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid and CIBERCV, Dr Esquerdo 46, Madrid 28007, Spain.

Department of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Münster, Germany.

出版信息

Eur Heart J. 2021 Feb 11;42(6):647-656. doi: 10.1093/eurheartj/ehaa1060.

DOI:10.1093/eurheartj/ehaa1060
PMID:33388778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7878012/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/cd0be566a2fa/ehaa1060f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/08006d1dab4a/ehaa1060f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/458c3e25ad33/ehaa1060f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/52c90a3c364a/ehaa1060f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/91f289e47fda/ehaa1060f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/cd0be566a2fa/ehaa1060f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/08006d1dab4a/ehaa1060f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/458c3e25ad33/ehaa1060f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/52c90a3c364a/ehaa1060f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/91f289e47fda/ehaa1060f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f9/7878012/cd0be566a2fa/ehaa1060f5.jpg

相似文献

1
The year in cardiovascular medicine 2020: valvular heart disease.2020年心血管医学领域：心脏瓣膜病
Eur Heart J. 2021 Feb 11;42(6):647-656. doi: 10.1093/eurheartj/ehaa1060.
2
The year in cardiovascular medicine 2021: valvular heart disease.2021年心血管医学领域：心脏瓣膜病
Eur Heart J. 2022 Feb 12;43(7):633-640. doi: 10.1093/eurheartj/ehab885.
3
Valvular heart disease: the influence of changing etiology on nosology.心脏瓣膜病：病因变化对疾病分类学的影响。
J Heart Valve Dis. 1994 Sep;3(5):516-26.
4
Echocardiographic detection of heart valve disease in a community cohort of asymptomatic Australians > 65 years with cardiovascular risk factors.超声心动图检测有心血管危险因素的无症状澳大利亚 > 65 岁社区队列人群中心脏瓣膜病。
Int J Cardiol. 2023 Feb 15;373:107-109. doi: 10.1016/j.ijcard.2022.11.045. Epub 2022 Nov 24.
5
The Year in Cardiovascular Medicine 2020: Valvular Heart Disease.2020年心血管医学年度回顾：心脏瓣膜病
Eur Heart J. 2021 Apr 21;42(16):1542-1543. doi: 10.1093/eurheartj/ehaa1024.
6
[Acquired valvular cardiopathies in Italy: the dimensions of the problem and variations in etiology].[意大利获得性心脏瓣膜病：问题规模及病因变化]
Cardiologia. 1993 Mar;38(3):185-90.
7
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).心房颤动合并心脏瓣膜病的抗栓治疗：欧洲心律协会（EHRA）和欧洲心脏病学会血栓工作组的联合共识文件，得到 ESC 心脏瓣膜病工作组、南非心脏协会（SA Heart）、心律学会（HRS）、亚太心律学会（APHRS）、南非心脏协会（SA Heart）和拉丁美洲心脏刺激和电生理学会（SOLEACE）的认可。
Europace. 2017 Nov 1;19(11):1757-1758. doi: 10.1093/europace/eux240.
8
Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study.心脏瓣膜钙化作为长期腹膜透析患者全因死亡率和心血管死亡率的重要预测指标：一项前瞻性研究。
J Am Soc Nephrol. 2003 Jan;14(1):159-68. doi: 10.1097/01.asn.0000038685.95946.83.
9
Valvular heart disease in pregnancy.妊娠期心脏瓣膜病。
Best Pract Res Clin Obstet Gynaecol. 2014 May;28(4):507-18. doi: 10.1016/j.bpobgyn.2014.03.009. Epub 2014 Apr 3.
10
Surgery for valvular heart disease: a population-based study in a Brazilian urban center.瓣膜性心脏病的手术治疗：巴西一城市中心的基于人群的研究。
PLoS One. 2012;7(5):e37855. doi: 10.1371/journal.pone.0037855. Epub 2012 May 29.

引用本文的文献

1
Epidemiology of Valvular Heart Disease in Asia Pacific Region.亚太地区心脏瓣膜病流行病学
JACC Asia. 2025 May 3;5(6):718-43. doi: 10.1016/j.jacasi.2025.03.011.
2
Emerging technologies for cardiac tissue engineering and artificial hearts.用于心脏组织工程和人工心脏的新兴技术。
Smart Med. 2023 Feb 16;2(1):e20220040. doi: 10.1002/SMMD.20220040. eCollection 2023 Feb.
3
Transcatheter Aortic Valve Replacement in Asia: Present Status and Future Perspectives.亚洲经导管主动脉瓣置换术：现状与未来展望

本文引用的文献

1
Impact of Mitral Regurgitation Severity and Left Ventricular Remodeling on Outcome After MitraClip Implantation: Results From the Mitra-FR Trial.经二尖瓣夹合术治疗后二尖瓣反流严重程度和左心室重构对预后的影响：Mitra-FR 试验结果。
JACC Cardiovasc Imaging. 2021 Apr;14(4):742-752. doi: 10.1016/j.jcmg.2020.07.021. Epub 2020 Sep 16.
2
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.经导管主动脉瓣置换术后阿司匹林联合或不联合氯吡格雷
N Engl J Med. 2020 Oct 8;383(15):1447-1457. doi: 10.1056/NEJMoa2017815. Epub 2020 Aug 30.
3
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement.
JACC Asia. 2021 Dec 7;1(3):279-293. doi: 10.1016/j.jacasi.2021.10.006. eCollection 2021 Dec.
4
Predictors of Mortality Following Aortic Valve Replacement in Aortic Stenosis Patients.主动脉瓣狭窄患者主动脉瓣置换术后的死亡预测因素
Pathophysiology. 2022 Mar 9;29(1):106-117. doi: 10.3390/pathophysiology29010010.
二叶式主动脉瓣形态与经导管主动脉瓣置换术后结局。
J Am Coll Cardiol. 2020 Sep 1;76(9):1018-1030. doi: 10.1016/j.jacc.2020.07.005.
4
Impact of arterio-ventricular interaction on first-phase ejection fraction in aortic stenosis.主动脉瓣狭窄中房室相互作用对射血分数第一时相的影响。
Eur Heart J Cardiovasc Imaging. 2021 May 10;22(6):650-657. doi: 10.1093/ehjci/jeaa154.
5
Progression of valvular calcification and risk of incident stroke: The Multi-Ethnic Study of Atherosclerosis (MESA).瓣膜钙化进展与卒中发生风险：动脉粥样硬化多民族研究（MESA）
Atherosclerosis. 2020 Aug;307:32-38. doi: 10.1016/j.atherosclerosis.2020.06.009. Epub 2020 Jul 5.
6
Transcatheter valve-in-valve implantation in failed aortic bioprosthetic valves: a word of caution in times of euphoria.经导管主动脉生物瓣膜置换术后瓣膜内瓣膜植入术：在一片乐观之时需谨慎。
Eur Heart J. 2020 Aug 1;41(29):2743-2746. doi: 10.1093/eurheartj/ehaa560.
7
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.自膨式瓣中瓣与商业可用经导管心脏瓣膜在高危和极高危重度主动脉瓣狭窄患者（PORTICO IDE）中的应用：一项随机、对照、非劣效性试验。
Lancet. 2020 Sep 5;396(10252):669-683. doi: 10.1016/S0140-6736(20)31358-1. Epub 2020 Jun 25.
8
Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.生物人工心脏瓣膜功能衰竭后经导管主动脉瓣植入术的长期疗效
Eur Heart J. 2020 Aug 1;41(29):2731-2742. doi: 10.1093/eurheartj/ehaa544.
9
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project.欧洲介入心脏病学图谱：欧洲经皮心血管介入协会（EAPCI）图谱项目
Eur Heart J. 2020 Jul 14;41(27):2579-2588. doi: 10.1093/eurheartj/ehaa475.
10
The Natural History of Severe Calcific Mitral Stenosis.严重钙化性二尖瓣狭窄的自然病史。
J Am Coll Cardiol. 2020 Jun 23;75(24):3048-3057. doi: 10.1016/j.jacc.2020.04.049.